Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 263 entries
Sorted by: Best Match Show Resources per page
Superdeformation in the bismuth nuclei.

Physical review. C, Nuclear physics

Asztalos S, Azaiez F, Becker JA, Bouneau S, Cederwall B, Clark RM, Deleplanque MA, Diamond RM, Duprat J, Fallon P, Farris LP, Henry EA, Hughes JR, Kelly WH, Lee IY, Macchiavelli AO, Porquet MG, Sharpey-Schafer JF, Stephens FS, Stoyer MA, Vo DT, Wilson AN.
PMID: 9970220
Phys Rev C Nucl Phys. 1995 Mar;51(3):R1052-R1056. doi: 10.1103/physrevc.51.r1052.

No abstract available.

Cite
Asztalos S, Azaiez F, Becker JA, et al. Superdeformation in the bismuth nuclei. Phys Rev C Nucl Phys. 1995;51(3):R1052-R1056doi: 10.1103/physrevc.51.r1052.
Asztalos, S., Azaiez, F., Becker, J. A., Bouneau, S., Cederwall, B., Clark, R. M., Deleplanque, M. A., Diamond, R. M., Duprat, J., Fallon, P., Farris, L. P., Henry, E. A., Hughes, J. R., Kelly, W. H., Lee, I. Y., Macchiavelli, A. O., Porquet, M. G., Sharpey-Schafer, J. F., Stephens, F. S., Stoyer, M. A., Vo, D. T., & Wilson, A. N. (1995). Superdeformation in the bismuth nuclei. Physical review. C, Nuclear physics, 51(3), R1052-R1056. https://doi.org/10.1103/physrevc.51.r1052
Asztalos, et al. "Superdeformation in the bismuth nuclei." Physical review. C, Nuclear physics vol. 51,3 (1995): R1052-R1056. doi: https://doi.org/10.1103/physrevc.51.r1052
Asztalos S, Azaiez F, Becker JA, Bouneau S, Cederwall B, Clark RM, Deleplanque MA, Diamond RM, Duprat J, Fallon P, Farris LP, Henry EA, Hughes JR, Kelly WH, Lee IY, Macchiavelli AO, Porquet MG, Sharpey-Schafer JF, Stephens FS, Stoyer MA, Vo DT, Wilson AN. Superdeformation in the bismuth nuclei. Phys Rev C Nucl Phys. 1995 Mar;51(3):R1052-R1056. doi: 10.1103/physrevc.51.r1052. PMID: 9970220.
Copy Download .nbib Format: NLM
Identification of the unfavored N=7 superdeformed band in 191Hg.

Physical review. C, Nuclear physics

Ahmad I, Becker JA, Brinkman MJ, Carpenter MP, Cederwall B, Crowell B, Deleplanque MA, Diamond RM, Fallon P, Farris LP, Garg U, Gassmann D, Henry EA, Henry RG, Hughes JR, Janssens RV, Khoo TL, Lauritsen T, Lee IY, Machiavelli AO, Moore EF, Nisius D, Stephens FS.
PMID: 9970322
Phys Rev C Nucl Phys. 1995 May;51(5):2400-2405. doi: 10.1103/physrevc.51.2400.

No abstract available.

Cite
Ahmad I, Becker JA, Brinkman MJ, et al. Identification of the unfavored N=7 superdeformed band in 191Hg. Phys Rev C Nucl Phys. 1995;51(5):2400-2405doi: 10.1103/physrevc.51.2400.
Ahmad, I., Becker, J. A., Brinkman, M. J., Carpenter, M. P., Cederwall, B., Crowell, B., Deleplanque, M. A., Diamond, R. M., Fallon, P., Farris, L. P., Garg, U., Gassmann, D., Henry, E. A., Henry, R. G., Hughes, J. R., Janssens, R. V., Khoo, T. L., Lauritsen, T., Lee, I. Y., Machiavelli, A. O., Moore, E. F., Nisius, D., & Stephens, F. S. (1995). Identification of the unfavored N=7 superdeformed band in 191Hg. Physical review. C, Nuclear physics, 51(5), 2400-2405. https://doi.org/10.1103/physrevc.51.2400
Ahmad, et al. "Identification of the unfavored N=7 superdeformed band in 191Hg." Physical review. C, Nuclear physics vol. 51,5 (1995): 2400-2405. doi: https://doi.org/10.1103/physrevc.51.2400
Ahmad I, Becker JA, Brinkman MJ, Carpenter MP, Cederwall B, Crowell B, Deleplanque MA, Diamond RM, Fallon P, Farris LP, Garg U, Gassmann D, Henry EA, Henry RG, Hughes JR, Janssens RV, Khoo TL, Lauritsen T, Lee IY, Machiavelli AO, Moore EF, Nisius D, Stephens FS. Identification of the unfavored N=7 superdeformed band in 191Hg. Phys Rev C Nucl Phys. 1995 May;51(5):2400-2405. doi: 10.1103/physrevc.51.2400. PMID: 9970322.
Copy Download .nbib Format: NLM
Neutron capture cross sections of 86Sr and 87Sr from 100 eV to 1 MeV, the conditions for the astrophysical s process, and the 87Rb-87Sr cosmochronometer.

Physical review. C, Nuclear physics

Bauer RW, Bazan G, Becker JA, Howe RE, Mathews GJ.
PMID: 9967249
Phys Rev C Nucl Phys. 1991 Apr;43(4):2004-2011. doi: 10.1103/physrevc.43.2004.

No abstract available.

Cite
Bauer RW, Bazan G, Becker JA, et al. Neutron capture cross sections of 86Sr and 87Sr from 100 eV to 1 MeV, the conditions for the astrophysical s process, and the 87Rb-87Sr cosmochronometer. Phys Rev C Nucl Phys. 1991;43(4):2004-2011doi: 10.1103/physrevc.43.2004.
Bauer, R. W., Bazan, G., Becker, J. A., Howe, R. E., & Mathews, G. J. (1991). Neutron capture cross sections of 86Sr and 87Sr from 100 eV to 1 MeV, the conditions for the astrophysical s process, and the 87Rb-87Sr cosmochronometer. Physical review. C, Nuclear physics, 43(4), 2004-2011. https://doi.org/10.1103/physrevc.43.2004
Bauer, et al. "Neutron capture cross sections of 86Sr and 87Sr from 100 eV to 1 MeV, the conditions for the astrophysical s process, and the 87Rb-87Sr cosmochronometer." Physical review. C, Nuclear physics vol. 43,4 (1991): 2004-2011. doi: https://doi.org/10.1103/physrevc.43.2004
Bauer RW, Bazan G, Becker JA, Howe RE, Mathews GJ. Neutron capture cross sections of 86Sr and 87Sr from 100 eV to 1 MeV, the conditions for the astrophysical s process, and the 87Rb-87Sr cosmochronometer. Phys Rev C Nucl Phys. 1991 Apr;43(4):2004-2011. doi: 10.1103/physrevc.43.2004. PMID: 9967249.
Copy Download .nbib Format: NLM
FDA Approval Summary: Sotorasib for .

Clinical cancer research : an official journal of the American Association for Cancer Research

Nakajima EC, Drezner N, Li X, Mishra-Kalyani PS, Liu Y, Zhao H, Bi Y, Liu J, Rahman A, Wearne E, Ojofeitimi I, Hotaki LT, Spillman D, Pazdur R, Beaver JA, Singh H.
PMID: 34903582
Clin Cancer Res. 2021 Dec 13; doi: 10.1158/1078-0432.CCR-21-3074. Epub 2021 Dec 13.

On May 28, 2021, the FDA granted accelerated approval to sotorasib (Lumakras, Amgen) for the treatment of adults with advanced non-small cell lung cancer (NSCLC) with a

Cite
Nakajima EC, Drezner N, Li X, et al. FDA Approval Summary: Sotorasib for . Clin Cancer Res. 2021;doi: 10.1158/1078-0432.CCR-21-3074.
Nakajima, E. C., Drezner, N., Li, X., Mishra-Kalyani, P. S., Liu, Y., Zhao, H., Bi, Y., Liu, J., Rahman, A., Wearne, E., Ojofeitimi, I., Hotaki, L. T., Spillman, D., Pazdur, R., Beaver, J. A., & Singh, H. (2021). FDA Approval Summary: Sotorasib for . Clinical cancer research : an official journal of the American Association for Cancer Research, . https://doi.org/10.1158/1078-0432.CCR-21-3074
Nakajima, Erica C, et al. "FDA Approval Summary: Sotorasib for ." Clinical cancer research : an official journal of the American Association for Cancer Research vol. (2021). doi: https://doi.org/10.1158/1078-0432.CCR-21-3074
Nakajima EC, Drezner N, Li X, Mishra-Kalyani PS, Liu Y, Zhao H, Bi Y, Liu J, Rahman A, Wearne E, Ojofeitimi I, Hotaki LT, Spillman D, Pazdur R, Beaver JA, Singh H. FDA Approval Summary: Sotorasib for . Clin Cancer Res. 2021 Dec 13; doi: 10.1158/1078-0432.CCR-21-3074. Epub 2021 Dec 13. PMID: 34903582.
Copy Download .nbib Format: NLM
Reply to Bernard.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

Beller JP, Teman NR.
PMID: 32728729
Eur J Cardiothorac Surg. 2020 Nov 01;58(5):1103-1104. doi: 10.1093/ejcts/ezaa202.

No abstract available.

Cite
Beller JP, Teman NR. Reply to Bernard. Eur J Cardiothorac Surg. 2020;58(5):1103-1104doi: 10.1093/ejcts/ezaa202.
Beller, J. P., & Teman, N. R. (2020). Reply to Bernard. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 58(5), 1103-1104. https://doi.org/10.1093/ejcts/ezaa202
Beller, Jared P, and Teman, Nicholas R. "Reply to Bernard." European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery vol. 58,5 (2020): 1103-1104. doi: https://doi.org/10.1093/ejcts/ezaa202
Beller JP, Teman NR. Reply to Bernard. Eur J Cardiothorac Surg. 2020 Nov 01;58(5):1103-1104. doi: 10.1093/ejcts/ezaa202. PMID: 32728729.
Copy Download .nbib Format: NLM
Subgroup Analyses in Oncology Trials: Regulatory Considerations and Case Examples.

Clinical cancer research : an official journal of the American Association for Cancer Research

Amatya AK, Fiero MH, Bloomquist EW, Sinha AK, Lemery SJ, Singh H, Ibrahim A, Donoghue M, Fashoyin-Aje LA, de Claro RA, Gormley NJ, Amiri-Kordestani L, Sridhara R, Theoret MR, Kluetz PG, Pazdur R, Beaver JA, Tang S.
PMID: 34117032
Clin Cancer Res. 2021 Nov 01;27(21):5753-5756. doi: 10.1158/1078-0432.CCR-20-4912. Epub 2021 Jun 11.

Subgroup analyses are assessments of treatment effects based on certain patient characteristics out of the total study population and are important for interpretation of pivotal oncology trials. However, appropriate use of subgroup analyses results for regulatory decision-making and product...

Cite
Amatya AK, Fiero MH, Bloomquist EW, et al. Subgroup Analyses in Oncology Trials: Regulatory Considerations and Case Examples. Clin Cancer Res. 2021;27(21):5753-5756doi: 10.1158/1078-0432.CCR-20-4912.
Amatya, A. K., Fiero, M. H., Bloomquist, E. W., Sinha, A. K., Lemery, S. J., Singh, H., Ibrahim, A., Donoghue, M., Fashoyin-Aje, L. A., de Claro, R. A., Gormley, N. J., Amiri-Kordestani, L., Sridhara, R., Theoret, M. R., Kluetz, P. G., Pazdur, R., Beaver, J. A., & Tang, S. (2021). Subgroup Analyses in Oncology Trials: Regulatory Considerations and Case Examples. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(21), 5753-5756. https://doi.org/10.1158/1078-0432.CCR-20-4912
Amatya, Anup K, et al. "Subgroup Analyses in Oncology Trials: Regulatory Considerations and Case Examples." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,21 (2021): 5753-5756. doi: https://doi.org/10.1158/1078-0432.CCR-20-4912
Amatya AK, Fiero MH, Bloomquist EW, Sinha AK, Lemery SJ, Singh H, Ibrahim A, Donoghue M, Fashoyin-Aje LA, de Claro RA, Gormley NJ, Amiri-Kordestani L, Sridhara R, Theoret MR, Kluetz PG, Pazdur R, Beaver JA, Tang S. Subgroup Analyses in Oncology Trials: Regulatory Considerations and Case Examples. Clin Cancer Res. 2021 Nov 01;27(21):5753-5756. doi: 10.1158/1078-0432.CCR-20-4912. Epub 2021 Jun 11. PMID: 34117032; PMCID: PMC8563387.
Copy Download .nbib Format: NLM
Two Hours of In Vivo Lung Perfusion Improves Lung Function in Sepsis-Induced Acute Respiratory Distress Syndrome.

Seminars in thoracic and cardiovascular surgery

Byler MR, Haywood NS, Money DT, Zhang A, Beller JP, Charles EJ, Chancellor WZ, Ta HQ, Stoler MH, Mehaffey JH, Laubach VE, Kron IL, Roeser ME.
PMID: 33713831
Semin Thorac Cardiovasc Surg. 2021 Mar 11; doi: 10.1053/j.semtcvs.2021.02.034. Epub 2021 Mar 11.

Sepsis is the leading cause of acute respiratory distress syndrome (ARDS) in adults and carries a high mortality. Utilizing a previously validated porcine model of sepsis-induced ARDS, we sought to refine our novel therapeutic technique of in vivo lung...

Cite
Byler MR, Haywood NS, Money DT, et al. Two Hours of In Vivo Lung Perfusion Improves Lung Function in Sepsis-Induced Acute Respiratory Distress Syndrome. Semin Thorac Cardiovasc Surg. 2021;doi: 10.1053/j.semtcvs.2021.02.034.
Byler, M. R., Haywood, N. S., Money, D. T., Zhang, A., Beller, J. P., Charles, E. J., Chancellor, W. Z., Ta, H. Q., Stoler, M. H., Mehaffey, J. H., Laubach, V. E., Kron, I. L., & Roeser, M. E. (2021). Two Hours of In Vivo Lung Perfusion Improves Lung Function in Sepsis-Induced Acute Respiratory Distress Syndrome. Seminars in thoracic and cardiovascular surgery, . https://doi.org/10.1053/j.semtcvs.2021.02.034
Byler, Matthew R, et al. "Two Hours of In Vivo Lung Perfusion Improves Lung Function in Sepsis-Induced Acute Respiratory Distress Syndrome." Seminars in thoracic and cardiovascular surgery vol. (2021). doi: https://doi.org/10.1053/j.semtcvs.2021.02.034
Byler MR, Haywood NS, Money DT, Zhang A, Beller JP, Charles EJ, Chancellor WZ, Ta HQ, Stoler MH, Mehaffey JH, Laubach VE, Kron IL, Roeser ME. Two Hours of In Vivo Lung Perfusion Improves Lung Function in Sepsis-Induced Acute Respiratory Distress Syndrome. Semin Thorac Cardiovasc Surg. 2021 Mar 11; doi: 10.1053/j.semtcvs.2021.02.034. Epub 2021 Mar 11. PMID: 33713831; PMCID: PMC8433279.
Copy Download .nbib Format: NLM
Cardiac rehabilitation following coronary artery bypass surgery.

American heart journal

Murray GC, Beller GA.
PMID: 6602538
Am Heart J. 1983 Jun;105(6):1009-18. doi: 10.1016/0002-8703(83)90404-0.

Early expectations of coronary revascularization prolonging life and reducing coronary events have been modified by 15 years' experience to mostly initial palliation of ischemic symptoms. Bypass surgery represents only a single therapeutic aspect for coronary atherosclerosis. Technically successful operations...

Cite
Murray GC, Beller GA. Cardiac rehabilitation following coronary artery bypass surgery. Am Heart J. 1983;105(6):1009-18doi: 10.1016/0002-8703(83)90404-0.
Murray, G. C., & Beller, G. A. (1983). Cardiac rehabilitation following coronary artery bypass surgery. American heart journal, 105(6), 1009-18. https://doi.org/10.1016/0002-8703(83)90404-0
Murray, G C, and Beller, G A. "Cardiac rehabilitation following coronary artery bypass surgery." American heart journal vol. 105,6 (1983): 1009-18. doi: https://doi.org/10.1016/0002-8703(83)90404-0
Murray GC, Beller GA. Cardiac rehabilitation following coronary artery bypass surgery. Am Heart J. 1983 Jun;105(6):1009-18. doi: 10.1016/0002-8703(83)90404-0. PMID: 6602538.
Copy Download .nbib Format: NLM
Vulnerable and Resilient Phenotypes in a Mouse Model of Anorexia Nervosa.

Biological psychiatry

Beeler JA, Mourra D, Zanca RM, Kalmbach A, Gellman C, Klein BY, Ravenelle R, Serrano P, Moore H, Rayport S, Mingote S, Burghardt NS.
PMID: 32950210
Biol Psychiatry. 2021 Dec 15;90(12):829-842. doi: 10.1016/j.biopsych.2020.06.030. Epub 2020 Jul 16.

BACKGROUND: Increased physical activity is a common feature of anorexia nervosa (AN). Although high activity levels are associated with greater risk of developing AN, particularly when combined with dieting, most individuals who diet and exercise maintain a healthy body...

Cite
Beeler JA, Mourra D, Zanca RM, et al. Vulnerable and Resilient Phenotypes in a Mouse Model of Anorexia Nervosa. Biol Psychiatry. 2020;90(12):829-842doi: 10.1016/j.biopsych.2020.06.030.
Beeler, J. A., Mourra, D., Zanca, R. M., Kalmbach, A., Gellman, C., Klein, B. Y., Ravenelle, R., Serrano, P., Moore, H., Rayport, S., Mingote, S., & Burghardt, N. S. (2021). Vulnerable and Resilient Phenotypes in a Mouse Model of Anorexia Nervosa. Biological psychiatry, 90(12), 829-842. https://doi.org/10.1016/j.biopsych.2020.06.030
Beeler, Jeff A, et al. "Vulnerable and Resilient Phenotypes in a Mouse Model of Anorexia Nervosa." Biological psychiatry vol. 90,12 (2021): 829-842. doi: https://doi.org/10.1016/j.biopsych.2020.06.030
Beeler JA, Mourra D, Zanca RM, Kalmbach A, Gellman C, Klein BY, Ravenelle R, Serrano P, Moore H, Rayport S, Mingote S, Burghardt NS. Vulnerable and Resilient Phenotypes in a Mouse Model of Anorexia Nervosa. Biol Psychiatry. 2021 Dec 15;90(12):829-842. doi: 10.1016/j.biopsych.2020.06.030. Epub 2020 Jul 16. PMID: 32950210; PMCID: PMC7855473.
Copy Download .nbib Format: NLM
In search of autophagy biomarkers in breast cancer: Receptor status and drug agnostic transcriptional changes during autophagy flux in cell lines.

PloS one

Mascia F, Mazo I, Alterovitz WL, Karagiannis K, Wu WW, Shen RF, Beaver JA, Rao VA.
PMID: 34990474
PLoS One. 2022 Jan 06;17(1):e0262134. doi: 10.1371/journal.pone.0262134. eCollection 2022.

Autophagy drives drug resistance and drug-induced cancer cell cytotoxicity. Targeting the autophagy process could greatly improve chemotherapy outcomes. The discovery of specific inhibitors or activators has been hindered by challenges with reliably measuring autophagy levels in a clinical setting....

Cite
Mascia F, Mazo I, Alterovitz WL, et al. In search of autophagy biomarkers in breast cancer: Receptor status and drug agnostic transcriptional changes during autophagy flux in cell lines. PLoS One. 2022;17(1):e0262134doi: 10.1371/journal.pone.0262134.
Mascia, F., Mazo, I., Alterovitz, W. L., Karagiannis, K., Wu, W. W., Shen, R. F., Beaver, J. A., & Rao, V. A. (2022). In search of autophagy biomarkers in breast cancer: Receptor status and drug agnostic transcriptional changes during autophagy flux in cell lines. PloS one, 17(1), e0262134. https://doi.org/10.1371/journal.pone.0262134
Mascia, Francesca, et al. "In search of autophagy biomarkers in breast cancer: Receptor status and drug agnostic transcriptional changes during autophagy flux in cell lines." PloS one vol. 17,1 (2022): e0262134. doi: https://doi.org/10.1371/journal.pone.0262134
Mascia F, Mazo I, Alterovitz WL, Karagiannis K, Wu WW, Shen RF, Beaver JA, Rao VA. In search of autophagy biomarkers in breast cancer: Receptor status and drug agnostic transcriptional changes during autophagy flux in cell lines. PLoS One. 2022 Jan 06;17(1):e0262134. doi: 10.1371/journal.pone.0262134. eCollection 2022. PMID: 34990474; PMCID: PMC8735604.
Copy Download .nbib Format: NLM
On the Shape-Selected, Ligand-Free Preparation of Hybrid Perovskite (CH.

Nanomaterials (Basel, Switzerland)

Bahnmüller UJ, Kuper H, Seewald T, Yalҫinkaya Y, Becker JA, Schmidt-Mende L, Weber SAL, Polarz S.
PMID: 34835821
Nanomaterials (Basel). 2021 Nov 13;11(11). doi: 10.3390/nano11113057.

Hybrid perovskite materials are one of the most promising candidates for optoelectronic applications, e.g., solar cells and LEDs, which can be produced at low cost compared to established materials. Although this field of research has seen a huge upsurge...

Cite
Bahnmüller UJ, Kuper H, Seewald T, et al. On the Shape-Selected, Ligand-Free Preparation of Hybrid Perovskite (CH. Nanomaterials (Basel). 2021;11(11)doi: 10.3390/nano11113057.
Bahnmüller, U. J., Kuper, H., Seewald, T., Yalҫinkaya, Y., Becker, J. A., Schmidt-Mende, L., Weber, S. A. L., & Polarz, S. (2021). On the Shape-Selected, Ligand-Free Preparation of Hybrid Perovskite (CH. Nanomaterials (Basel, Switzerland), 11(11), . https://doi.org/10.3390/nano11113057
Bahnmüller, Ulrich Johannes, et al. "On the Shape-Selected, Ligand-Free Preparation of Hybrid Perovskite (CH." Nanomaterials (Basel, Switzerland) vol. 11,11 (2021). doi: https://doi.org/10.3390/nano11113057
Bahnmüller UJ, Kuper H, Seewald T, Yalҫinkaya Y, Becker JA, Schmidt-Mende L, Weber SAL, Polarz S. On the Shape-Selected, Ligand-Free Preparation of Hybrid Perovskite (CH. Nanomaterials (Basel). 2021 Nov 13;11(11). doi: 10.3390/nano11113057. PMID: 34835821; PMCID: PMC8623308.
Copy Download .nbib Format: NLM
Setting of Plaster of Paris.

The Dental register

Belcher JA.
PMID: 33701107
Dent Regist. 1899 Jul;53(7):333.

No abstract available.

Cite
Belcher JA. Setting of Plaster of Paris. Dent Regist. 1899;53(7):333
Belcher, J. A. (1899). Setting of Plaster of Paris. The Dental register, 53(7), 333.
Belcher, J A. "Setting of Plaster of Paris." The Dental register vol. 53,7 (1899): 333.
Belcher JA. Setting of Plaster of Paris. Dent Regist. 1899 Jul;53(7):333. PMID: 33701107; PMCID: PMC6970660.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 263 entries